East Meets West in Innovative Technologies for the Treatment of Coronary Artery Disease

"Sahajanand Medical Technologies PVT.LTD (SMTPL) is the first stent manufacturing company outside the US to launch the Paclitaxel Eluting 'Infinnium Stent' - used in nearly 25 countries worldwide - and the Sirolimus Eluting 'Supralimus Stent'.



- SIMPLE 1 data, presented at Euro PCR 2003 with extended follow-up at TCT 2004, has impressed interventionalists worldwide.
- SIMPLE 2, a prospective multi-center trial, has completed enrollment in 8 centers. Watch for 6-month follow-up data at TCT 2005. Once again 'East meets West'".

Source : TCTMD e-letter - What's New the Week of July 5, 2005

To access the EuroPCR online news, click here.

Strategic solutions for Pharmaceutical, Biotechnology and Medical Device Companies:

"As a leading global provider of discovery and development services and products for pharmaceutical, biotechnology and medical device companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven discovery through post-market resources, the company also offers compound partnering opportunities. PPD has more than 7,100 professionals worldwide with offices in 28 countries."

Treatment of Coronary Artery Disease :
Heart Center Patient Programme: click here.
Source: Heart Center Online.

Upcoming event: November 6-10/05: Biosciences and Medical Devices Solutions: meet SRI @ the BIO 2005 event!

SRI International is an independent, nonprofit research institute conducting contract research and development for government agencies, commercial businesses, foundations, and other organizations. SRI also brings its innovations to the marketplace by licensing its technologies and creating new ventures.

The Weldon B. Gibson Achievement Award, established in honor of Senior Director Emeritus Dr. Weldon B. (Hoot) Gibson, recognizes outstanding contributions, by an SRI employee, that have had a noteworthy impact on the standard of living and on the peace and prosperity of society, and have added special luster to the reputation of SRI.

Phil Green 2003

Phil Green's contributions to the fields of ultrasonic imaging and minimally invasive "robotic" surgery have had tremendous impact on the practice of medicine.

Over a 25-year period, Green led more than 30 inventions that made ultrasound a usable medical diagnostic tool; it is now a primary method of imaging the human body. In the early 1980s, Green had an insight that would prove to revolutionize minimally invasive surgery: a robotic system, controlled remotely by the surgeon, that gives the full sensory experience of conventional hands-on "open" surgery.

Intuitive Surgical, an SRI spin-off company, developed and is commercializing the da Vinci™ Surgical System. Today, the company is the recognized leader in operative surgical robotics.

Source : SRI International.

Biosciences and Medical Devices Solutions at BIO 2005 :

SRI will showcase its drug discovery and development and medical product development services at BIO 2005 at the American Association of Pharmaceutical Scientists' annual meeting in Nashville, TN
from November 6-10, 2005.